NCT01959035View on ClinicalTrials.gov

Aripiprazole Once-monthly in Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole once-monthly

400 or 300 mg/month; 6 intramuscular (IM) injections starting at baseline

Trial Locations (1)

92102

US006, San Diego

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

H. Lundbeck A/S

INDUSTRY